Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PTGX | DVAX | GYRE | ||
| Company | Protagonist Therapeutics Inc | Dynavax Technologies | Gyre Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 24.61 | 11.11 | 16.33 | ||
| High | 25.23 | 11.26 | 17.25 | ||
| Low | 24.22 | 11.03 | 15.90 | ||
| Last | 25.15 | 11.21 | 17.11 | ||
| Change | +0.49 | +0.04 | +0.78 | ||
| % Change | +1.99% | +0.36% | +4.78% | ||
| Volume | 461,200 | 1,876,200 | 190,200 | ||
| 20-Day Average Volume | 544,255 | 2,108,980 | 77,400 | ||
| Previous Close | 24.66 | 11.17 | 16.33 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 26.89 | 11.81 | 16.28 | ||
| 20-Day Raw Stochastic | 18.64% | 10.98% | 90.88% | ||
| 20-Day Relative Strength | 41.01% | 35.40% | 50.97% | ||
| Weighted Alpha | +16.00 | -5.90 | +30.38 | ||
| Today's Opinion | 24% Buy | 100% Sell | 8% Buy | ||
| Previous Opinion | 24% Buy | 100% Sell | 8% Buy | ||
| Last Month's Opinion | 80% Buy | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.80% since 04/19/24 | -5.00% since 04/19/24 | +10.32% since 04/19/24 | ||
| Low | 24.22 on 04/26/24 | 11.03 on 04/26/24 | 15.35 on 04/25/24 | ||
| High | 27.78 on 04/23/24 | 12.08 on 04/23/24 | 17.25 on 04/26/24 | ||
| 1-Month | |||||
| %Chg | -10.18% since 03/26/24 | -9.38% since 03/26/24 | +1.91% since 03/26/24 | ||
| Low | 24.22 on 04/26/24 | 11.03 on 04/26/24 | 13.32 on 04/10/24 | ||
| High | 29.27 on 03/28/24 | 12.67 on 04/01/24 | 18.33 on 03/28/24 | ||
| 3-Month | |||||
| %Chg | +0.88% since 01/26/24 | -15.84% since 01/26/24 | +14.60% since 01/26/24 | ||
| Low | 24.22 on 04/26/24 | 11.03 on 04/26/24 | 10.41 on 02/13/24 | ||
| High | 33.34 on 03/01/24 | 13.41 on 01/29/24 | 26.37 on 02/27/24 | ||
| 6-Month | |||||
| %Chg | +76.99% since 10/26/23 | -21.66% since 10/26/23 | +111.63% since 10/26/23 | ||
| Low | 13.75 on 10/27/23 | 11.03 on 04/26/24 | 5.88 on 10/31/23 | ||
| High | 33.34 on 03/01/24 | 15.15 on 11/03/23 | 30.40 on 12/21/23 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,465,616 | 1,466,974 | 1,461,587 | ||
| Shares Outstanding, K | 58,275 | 130,863 | 85,423 | ||
| Annual Sales | 60,000,000 | 232,280,000 | 113,450,000 | ||
| Annual Net Income | -78,960,000 | -6,390,000 | -92,930,000 | ||
| Last Quarter Sales | 60,000,000 | 55,600,000 | 113,450,000 | ||
| Last Quarter Net Income | 27,340,000 | 220,000 | -89,150,000 | ||
| 60-Month Beta | 2.01 | 1.26 | 2.11 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.44 on 02/27/24 | 0.00 on 02/22/24 | -0.60 on 10/26/23 | ||
| Latest Earnings Date | 05/02/24 | 05/08/24 | 05/20/24 | ||
| Most Recent Dividend | N/A | N/A | 0.569 on 08/20/15 | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||